Oncotype DX
Making decisions after a breast cancer diagnosis can be complex, especially when it comes to chemotherapy. This video explains the Oncotype DX test, a groundbreaking genomic test that analyzes the unique biology of your tumor to help predict the chance of recurrence and—most importantly—clarify who will truly benefit from chemotherapy. Learn how this powerful tool helps you and your doctor make a more informed and personalized treatment decision.
In this video, we cover:
What is a Genomic Test? A simple guide to how the Oncotype DX test looks at the activity of 21 specific genes within your tumor to understand its behavior.
How the Test is Done: We explain the process, which uses a small amount of the tissue already removed during your initial biopsy or surgery.
Understanding Your Recurrence Score®: Learn how to interpret the main result—a score between 0 and 100—and what a low, intermediate, or high score means for your treatment path.
Chemo or No Chemo? See how the score provides crucial insight into whether adding chemotherapy to hormone therapy will significantly reduce your risk of the cancer returning.
Making a Shared Decision: How this test empowers you to have a more confident conversation with your oncologist to choose the right plan for you.